DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 74 filers reported holding DERMA SCIENCES INC in Q2 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $5,293,000 | -26.0% | 635,450 | +2.6% | 0.36% | -18.0% |
Q2 2014 | $7,156,000 | -10.4% | 619,110 | -1.7% | 0.44% | -6.7% |
Q1 2014 | $7,988,000 | +55.6% | 629,990 | +32.8% | 0.48% | +68.6% |
Q4 2013 | $5,134,000 | -3.7% | 474,510 | +10.1% | 0.28% | -15.0% |
Q3 2013 | $5,333,000 | -9.0% | 430,810 | -1.9% | 0.33% | -14.4% |
Q2 2013 | $5,862,000 | – | 439,160 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |